Changes in Oxidative Stress Markers in Pregnant Women of Advanced Maternal Age with Gestational Diabetes and Their Predictive Value for Neurodevelopmental Impact
Yabing Wang,Zhenling Fan,Jianli Ren,Lin Ma
DOI: https://doi.org/10.2147/dmso.s475385
2024-10-29
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yabing Wang, 1 Zhenling Fan, 2 Jianli Ren, 3 Lin Ma 4 1 Department of Obstetrical, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, Hebei Province, People's Republic of China; 2 Department of Hemodialysis, Handan Mingren Hospital, Handan, Hebei Province, People's Republic of China; 3 Department of Supplies, Peking University Third Hospital Chongli, Beijing, People's Republic of China; 4 Department of Gynecology and Obstetrics, Zhengdingxian People's Hospital, Shijiazhuang, Hebei Province, People's Republic of China Correspondence: Yabing Wang, Email Objective: To explore the relationship between changes in oxidative stress markers in pregnant women of advanced maternal age with gestational diabetes mellitus (GDM) and adverse pregnancy outcomes and neonatal neurodevelopment, as well as their predictive value. Methods: Two hundred pregnant women of advanced maternal age were selected and divided into Group A (normal blood sugar) and Group B (GDM) based on the 75 g (Oral Glucose Tolerance Test) OGTT results. Oxidative stress markers were measured, and pregnancy outcomes and neonatal Neonatal Behavioral Assessment Scale (NABA) scores were recorded. Results: Malondialdehyde (MDA) levels in Group B were higher than those in Group A, while Glutathione (GSH) and Superoxide Dismutase (SOD) levels were lower. Group B had higher rates of adverse pregnancy outcomes and neurological abnormalities than Group A. The Area Under the Curve (AUC) values for serum MDA, GSH, and SOD levels combined prediction were higher than those for individual predictions (P< 0.05). Conclusion: Oxidative stress markers in pregnant women of advanced maternal age with GDM are associated with adverse pregnancy outcomes and neonatal abnormalities, and combined prediction has good predictive efficiency (AUC> 0.7). Keywords: pregnant women of advanced maternal age with GDM, oxidative stress markers, pregnancy outcomes, neurodevelopment, correlation, predictive value With the continuous exacerbation of the aging population trend, the incidence of advanced maternal age pregnancies is gradually increasing. 1 Gestational diabetes mellitus (GDM) as a common complication of pregnancy has attracted widespread clinical attention. 2 GDM was first officially identified by O'Sullivan and Mahan in 1964 3 and is characterized by the onset of high blood sugar levels during pregnancy. 4 As global obesity rates continue to soar, the prevalence of GDM among pregnant women is increasing, and this condition significantly heightens the risk of numerous pregnancy complications. 5 Globally, statistics show that about 2% to 10% of pregnant women develop GDM, 6 and the prevalence of GDM rises with gestational age from 25% in 23rd week of gestation, 7 up to 33% in third trimester of pregnancy. 8 Previous large-scale studies have reported obstetric risks related to diabetes, such as macrosomia, hypertension, and neonatal hypoglycemia. 9–11 Another study by Ye et al identified a significant association of GDM with pregnancy complications when adjusted for confounders, 12 and a significantly increased risk of developing chronic diseases such as diabetes, metabolic syndrome, and cardiovascular disease in GDM patients and their infants has also been found. 13 Oxidative stress has been identified as part of the physiopathology of various diseases, with a particular emphasis on metabolic diseases like metabolic syndrome and diabetes, although it is also present in conditions such as obesity and pregnancy. 14 Oxidative stress leads to the excessive generation of oxygen-free radicals in the body, damaging cell membranes, proteins, and nucleic acids, thereby accelerating the development of diabetes-related complications. 15 Robust evidence has shown that GDM is marked by elevated oxidative stress, which may contribute to increased cardiovascular risk and postpartum insulin resistance. 14,16,17 Oxidative stress plays a key role in the development and progression of GDM, creating a vicious cycle with inflammation. 14 Therefore, monitoring the changes in oxidative stress marker levels in GDM women can help deepen the understanding of the pathogenesis of GDM. This study aimed to explore the relationship between the dynamic changes in oxidative stress marker levels in pregnant women of advanced maternal age with GDM and adverse pregnancy outcomes. It is hoped that the results of this study can provide more effective prediction and intervention strategies for clinical practice to help reduce the occurrence of adverse outcomes in pregnant women of advanced -Abstract Truncated-
endocrinology & metabolism